Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study

BACKGROUND: Nucleos(t)ide analog (NA) has shown limited effectiveness against hepatitis B surface antigen (HBsAg) clearance in chronic hepatitis B (CHB) patients. AIM: To evaluate the efficacy and safety of add-on peginterferon α-2a (peg-IFN α-2a) to an ongoing NA regimen in CHB patients. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Feng-Ping, Yang, Ying, Li, Mei, Liu, Yi-Xin, Li, Ya-Ping, Wang, Wen-Jun, Shi, Juan-Juan, Zhang, Xin, Jia, Xiao-Li, Dang, Shuang-Suo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152523/
https://www.ncbi.nlm.nih.gov/pubmed/32308352
http://dx.doi.org/10.3748/wjg.v26.i13.1525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152523/
https://www.ncbi.nlm.nih.gov/pubmed/32308352
http://dx.doi.org/10.3748/wjg.v26.i13.1525

Ejemplares similares